Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
Arulkumaran Shanmugam(New York Medical College), Raj K. Tiwari(New York Medical College)
Cited by 176
Related Papers
Artificial Intelligence and Healthcare: A Journey through History, Present Innovations, and Future Possibilities
|Life|2024|181
Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3′-Diindolylmethane in Thyroid Cancer
|PLoS ONE|2011|82
Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions
|Biomedicines|2025|52
Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence
|Molecular Cancer|2012|47